Evidence map›Paper›PMID 35955676›Full record

ArticleInternational journal of molecular sciences2022

Enhancer Regulation of Dopaminergic Neurochemical Transmission in the Striatum.

Laszlo G Harsing, Joseph Knoll, Ildiko Miklya

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Laszlo G HarsingDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, Nagyvarad ter 4, 1089 Budapest, Hungary.
Joseph KnollDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, Nagyvarad ter 4, 1089 Budapest, Hungary.
Ildiko MiklyaDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, Nagyvarad ter 4, 1089 Budapest, Hungary.
Semmelweis University · HU

Funding

Fujimoto Pharmaceutical Corporation, Osaka, Japan noneMinistry of Interior TKP2021-EGA-25
6 · The paper itself

Abstract

The trace amine-associated receptor 1 (TAAR1) is a Gs protein-coupled, intracellularly located metabotropic receptor. Trace and classic amines, amphetamines, act as agonists on TAAR1; they activate downstream signal transduction influencing neurotransmitter release via intracellular phosphorylation. Our aim was to check the effect of the catecholaminergic activity enhancer compound ((-)BPAP, (

Indexed as

DopamineMethamphetamineAnimalsCorpus StriatumDopamine AgentsDopamine Plasma Membrane Transport ProteinsRatsReceptors, G-Protein-CoupledDopamineDopamine AgentsDopamine Plasma Membrane Transport ProteinsMethamphetamineReceptors, G-Protein-Coupled[3H]dopamine release(−)BPAPcatecholaminergic activity enhancer effectrat striatumtrace amine-associated receptor 1

Identifiers

PMID35955676
PMCPMC9369307
OpenAlexW4289313666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.